vaccine development

Pharma

France suspends use of Valneva chikungunya shot in older adults

As safety flags hang over Valneva’s chikungunya vaccine in the U.S. and beyond, French authorities are clamping down on the shot’s use in older adults.

Fraiser Kansteiner Apr 28, 2025 10:35am

FDA asks Novavax for data pledge amid stalled COVID shot review

Apr 23, 2025 9:17am

FDA misses decision deadline for Novavax COVID vaccine

Apr 3, 2025 3:28pm

CBER chief Peter Marks resigns from FDA

Mar 31, 2025 10:50am

AstraZeneca-Alteogen, Taiho, WuXi—Fierce Pharma Asia

Mar 21, 2025 9:10am

Bavarian Nordic CEO highlights travel health as key sales driver

Mar 6, 2025 9:04am